SIGNORELLI, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 7.334
AS - Asia 3.109
EU - Europa 2.622
SA - Sud America 648
AF - Africa 449
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 14.173
Nazione #
US - Stati Uniti d'America 7.093
SG - Singapore 1.657
CN - Cina 953
IT - Italia 736
IE - Irlanda 604
BR - Brasile 567
UA - Ucraina 469
RU - Federazione Russa 324
CI - Costa d'Avorio 300
CA - Canada 209
VN - Vietnam 178
SE - Svezia 130
SN - Senegal 106
DE - Germania 89
IN - India 80
GB - Regno Unito 65
KR - Corea 46
NL - Olanda 33
FR - Francia 32
AR - Argentina 31
UZ - Uzbekistan 26
TR - Turchia 22
BD - Bangladesh 21
CH - Svizzera 20
MX - Messico 19
CO - Colombia 18
ES - Italia 18
PL - Polonia 18
IQ - Iraq 17
ZA - Sudafrica 17
AT - Austria 16
FI - Finlandia 16
JP - Giappone 16
HK - Hong Kong 14
ID - Indonesia 14
IR - Iran 14
EC - Ecuador 13
BE - Belgio 11
PK - Pakistan 10
CL - Cile 7
BG - Bulgaria 6
GR - Grecia 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
LB - Libano 5
NG - Nigeria 5
PS - Palestinian Territory 5
RS - Serbia 5
SA - Arabia Saudita 5
TN - Tunisia 5
AL - Albania 4
DZ - Algeria 4
KZ - Kazakistan 4
MA - Marocco 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
AZ - Azerbaigian 3
BJ - Benin 3
BO - Bolivia 3
EU - Europa 3
KE - Kenya 3
LT - Lituania 3
NP - Nepal 3
PA - Panama 3
RO - Romania 3
BH - Bahrain 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
MY - Malesia 2
PE - Perù 2
PY - Paraguay 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AQ - Antartide 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.173
Città #
Dallas 1.275
Singapore 910
Santa Clara 903
Chandler 661
Dublin 600
Jacksonville 577
Chicago 328
Abidjan 299
Boardman 267
Ashburn 239
Houston 235
Catania 205
Lawrence 167
Nanjing 167
Andover 164
Beijing 162
Cambridge 162
Toronto 148
Hefei 113
Los Angeles 109
Dakar 106
Des Moines 97
Moscow 87
Wilmington 85
The Dalles 84
Civitanova Marche 79
San Mateo 73
Nanchang 66
Saint Petersburg 51
Ho Chi Minh City 48
Shenyang 47
Seoul 45
Buffalo 44
Bremen 41
Dong Ket 41
São Paulo 41
New York 40
Council Bluffs 37
Hebei 36
Columbus 34
Kochi 33
Ottawa 32
Palermo 31
Falls Church 30
Hanoi 30
Padova 30
Milan 28
Tianjin 27
Florence 26
Jiaxing 26
Changsha 23
Rome 22
Washington 19
North Charleston 17
Norwalk 17
Seattle 17
Tokyo 16
Denver 15
Johannesburg 15
Örebro 15
Boston 14
Rio de Janeiro 14
Amsterdam 13
Hong Kong 13
Poplar 13
Ardabil 12
Montreal 12
Stockholm 12
Warsaw 12
Belo Horizonte 11
Brussels 11
Chennai 11
Grafing 11
Jinan 11
San Francisco 11
Tashkent 11
Atlanta 10
Brasília 10
Brooklyn 10
Den Haag 10
Hangzhou 10
Kunming 10
Mumbai 10
Ningbo 10
Phoenix 10
Porto Alegre 10
Augusta 9
Ankara 8
Boydton 8
Civitavecchia 8
Haiphong 8
Liberty Lake 8
Munich 8
Salerno 8
Syracuse 8
Zhengzhou 8
Mexico City 7
Orem 7
Pozzo Di Gotto 7
Vienna 7
Totale 9.743
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 377
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis 295
Inflammation in peripheral arterial disease (PAD). 157
Il Rasario. Semeiotica medica 152
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 150
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 149
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 146
Association of high alpha2-Heremans–Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass 144
A systematic review of arterial stiffness, wave reflection and air pollution 140
A randomized, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment of patients with peripheral arterial disease and haemodialysis with propyonil L-carnitine 139
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 137
Carotid Intima-Media Thickness and Liver Histology in Hemodialysis Patients with Non-Alcoholic Fatty Liver Disease 133
Acute deep vein thrombosis (DVT) of the lower limbs in a 32-year-old man with chronic hypoplasia of the inferior vena cava (HIVC) without risk factors. 126
Venous thromboembolism in hospital emergency room. A retrospective study on climatic effect 124
Analysis of G(-174) CIL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease 121
Inhibition of Heme Oxygenase Antioxidant Activity Exacerbates Hepatic Steatosis and Fibrosis In Vitro 120
Aerobic exercise and Orexin A: role of sympathetic activity and redox system 120
Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study 117
Tolerability and clinical efficacy of desmin in the treatment of superficial thrombovaricophlebitis 117
Correlation between some metabolic markers of vascular risk and carotid artery intima-media thickness in postmenopausal women 117
A Real-Life Survey of Venous Thromboembolic Events Occurring in Myeloma Patients Treated in Third Line with Second-Generation Novel Agents 116
A non-alcohol-related case of Madelung's disease: Challenging patient with progressive jugular vein distension 115
Arterial Plaques in Peripheral Arteries Diagnosed by Ultrasound in a Cohort of Patients with Type 2 Diabetes Mellitus 112
Proinflammatory circulating molecules in peripheral arterial disease 109
Effect of LPC on functional parameters and oxidative profile in type 2 diabetes-associated PAD 109
Anticoagulants and osteoporosis 109
Groundwater-based water wells characterization from Guinea Bissau (Western Africa): A risk evaluation for the local population 108
Inflammation and peripheral arterial disease: the value of circulating biomarkers (Review). 106
Changes in cerebral vasomotor reactivity in relation to respiratory and metabolic stimuli: an analysis of its behavior in hypertensive and normotensive subjects. 105
A severe myopathy case in aged patient treated with high statin dosage 105
Analisi della correlazione tra fattori di rischio aterotrombotico e diagnosi ultrasonografica di lesioni vascolari dell’arteria carotide, in una popolazione di soggetti ambulatoriali asintomatici 103
Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients 102
Behaviour of some indicators of oxidative stress in postmenopausal and fertile women 102
Transition and heavy metals compared to oxidative parameter balance in patients with deep vein thrombosis: A case-control study 102
Arterial Wall Characteristics in Patients With Peripheral Arterial Disease. Preliminary Data Obtained at Different Arterial Sites by Radiofrequency-Based Wall Tracking System 102
Analisi della correlazione tra fattori di rischio aterotrombotico e diagnosi ultrasonografica di lesioni vascolari dell’arteria carotide, in una popolazione di soggetti asintomatici 101
Deep vein thrombosis related to environment (Review) 101
The Heme Oxygenase System in Hematological Malignancies 101
Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis 101
Behaviour of the carotid wall in menopausal women with an without arterial hypertension 99
A Case of Acquired Factor V Deficiency in Patient with Bleeding 98
Circulating miR-130a, miR-27b, and miR-210 in Patients With Peripheral Artery Disease and Their Potential Relationship With Oxidative Stress: A Pilot Study 97
The chance case history of an unusual disease: mesenteric panniculitis. 96
Metals and neurodegenerative diseases. A systematic review 96
Dectin-1 and TIM3 Expression in Deep Vein Thrombosis of Lower Limbs (DVTLL) 96
Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects 95
Oxidative stress in peripheral arterial disease (PAD) mechanism and biomarkers 92
Biomarkers on pathophysiology of chronic ischemia. Potential role of mRNAs and oxidative stress in peripheral arterial disease 91
Considerazioni sull'impiego dell'urokinasi nel trattamento dell'insufficienza arteriosa cronica periferica. 91
Association of high alpha(2)-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass 91
Duration of menopause and behaviour of malondialdehyde, lipids, lipoproteins and carotid wall artery intima – media thickness 90
Familial 1q22 microduplication associated with psychiatric disorders, intellectual disability and late-onset autoimmune inflammatory response 90
Spontaneous bleeding in systemic lupus erythematosus: Endovascular treatment of two rare cases 90
Chronic peripheral arteriopathy is associated with seropositivity to Chlamydia pneumoniae 89
Platelet-Derived Microparticles (MPs) and Thrombin Generation Velocity in Deep Vein Thrombosis (DVT): Results of a Case–Control Study 89
Il quadro capillaroscopico nella sclerodermia: nostra esperienza. 88
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease 87
Peripheral artery disease and osteoporosis: Not only age-related (Review) 87
Incidence of extra-genital vascular disease in patients with erectile dysfunction of arterial origin 86
Oxidative stress and endothelial damage in patients with non symptomatic carotid atherosclerosis 86
Kidney and heavy metals - The role of environmental exposure (Review) 86
The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations 86
Pathophysiology of chronic peripheral ischemia: New perspectives. 86
Paget's Disease of Bone and Cardiovascular Risk: a Pilot Study 86
ICAM-1 and SRD5A1 gene polymorphisms in symptomatic peripheral arterial disease 84
Duration of menopause and behaviour of malondialdehyde, lipids, lipoproteins and carotid wall intima-media thickenss 84
Distribuzione e tipologia ecotomografica delle lesioni macrocircolatorie nel diabete mellito tipo II 84
Oxidative stress, nitric oxide, endothelial dysfunction and tinnitus 83
Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels 83
Risultati di uno screening epidemiologico condotto su popolazione femminile per la valutazione della arteriosclerosi delle arterie carotidi extracraniche: progetto donna in Catania 81
Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression 81
Inflammation and Peripheral Arterial Disease 81
Inter-Relationship between Platelet-Derived Microparticles and Oxidative Stress in Patients with Venous Thromboembolism 80
Insights from experiences on antiplatelet drugs in stroke prevention: A review 80
The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role? 80
Endothelin-1 in arterial hypertension after cold pressor test 79
Varicose symptom without varicose veins: the hypotonic phlebopathy, epidemiology and pathophysiology. The Acireale project 79
Hematological Diseases and Osteoporosis 79
Decreased bone cortical density at the forearm in subjects with subclinical peripheral arterial disease 78
Erectile dysfunction and sistemic vascular disease. 78
How to treat patients with essential hypertension and peripheral arterial disease 78
Ultrasound diagnosis of carotid artery lesion in a population of asymptomatic subjects presenting atherosclerosis risk factors 78
Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery disease 78
Role of Ademetionine (S-Adenosylmethionine) in cyclosporin-induced cholestasis 77
Oxidative stress and white blood cell activation in chronic and severe ischemia of peripheral vascular disease 77
Pathophysiology of Peripheral Arterial Disease (PAD): A Review on Oxidative Disorders 77
Prevalence of high ankle-brachial index (ABI) in general population of Southern Italy, risk factor profiles and systemic cardiovascular co-morbidity: An epidemiological study 76
Erectile dysfunction and systemic vascolar disease 76
Peak systolic velocity in patients with arterial erectile dysfunction and peripheral arterial disease 76
Neonatal Systemic Thrombosis: An Updated Overview 76
Infections: Patients with Peripheral Arterial Disease and Those with Risk Factors for Cardiovascular Diseases Compared to Normal Subjects 76
High circulating levels of cytockines (IL6 and TNFα), adhesion molecules (VICAM-1 and ICAM-1) and selectines in patients with peripheral arterial disease at rest and after a treadmill-test 75
Postphlebitic syndrome: clinical activity and tolerability of desmin, new LMW dermatan sulfate 75
Studio delle correlazioni tra marcatori metabolici del rischio vascolare ed il parametro ispessimento medio-intimale vascolare, in una popolazione di pazienti con obesità centrale 75
Erratum: Total Hemi-overgrowth in Pigmentary Mosaicism of the (Hypomelanosis of) Ito Type: Eight Case Reports (Medicine 95:10 (e2705)) (2016) Medicine (United States), 95 (15) 75
Oxidative stress and inflammation: Their role in the pathogenesis of peripheral artery disease with or without type 2 diabetes mellitus 74
Galactin-3: un marker per la prevenzione della trombosi 74
Environmental determinants, biomarkers and chronic disease (Catania, Italy). 73
Effects of long-term hormone replacement therapy on arterial wall thickness, lipids, lipoproteins and fibrinogen and antithrombi III 73
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type III diabetcs with peripheral arterial disease 73
Totale 10.164
Categoria #
all - tutte 49.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.560


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021573 0 0 0 0 0 36 133 0 82 51 197 74
2021/20221.269 140 189 11 20 220 26 182 42 95 19 47 278
2022/20232.108 180 81 33 199 226 346 9 400 510 27 58 39
2023/2024833 53 162 29 38 34 159 13 58 2 37 170 78
2024/20253.432 41 579 201 178 728 427 137 149 214 318 266 194
2025/20264.016 406 343 1.417 541 1.133 176 0 0 0 0 0 0
Totale 14.485